Lapatinib Completed Phase 2 Trials for Stage IV Breast Cancer / Estrogen Receptor Positive / Stage IIIB Breast Cancer / Recurrent Breast Carcinoma / Stage IIIC Breast Cancer / Male Breast Carcinoma / Progesterone Receptor Positive Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00118157Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen